Description
An NK1 receptor antagonist (Ki = 0.95 nM); selective for human NK1 over human NK2 and NK3 and rat NK1 (Kis = >1,500 nM); selective for NK1 over 50 G protein-coupled receptors, monoamine transporters, and ion channels when used in the nanomolar range; decreases the maximal response to substance P in isolated guinea pig ileum; inhibits substance P-induced scratching, biting, and licking in mice at doses of 1-10 mg/kg; decreases NK agonist-induced foot tapping in gerbils (ID50s = 1.5 mg/kg, i.p., or 0.5 mg/kg, oral).
Formal name: N,α,α-trimethyl-N-[4-(2-methylphenyl)-6-(4-methyl-1-piperazinyl)-3-pyridinyl]-3,5-bis(trifluoromethyl)-benzeneacetamide
Synonyms: Ro 67-31898/000
Molecular weight: 578.6
CAS: 290297-26-6
Purity: ≥98%
Formulation: A solid
Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Neuroscience|Pain Research